Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4215578
Max Phase: Preclinical
Molecular Formula: C70H121N15O17
Molecular Weight: 1444.83
Molecule Type: Small molecule
Associated Items:
ID: ALA4215578
Max Phase: Preclinical
Molecular Formula: C70H121N15O17
Molecular Weight: 1444.83
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCC)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@]1(C)CCCC=CCCC[C@@](C)(NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N1)[C@@H](C)CC)C(N)=O
Standard InChI: InChI=1S/C70H121N15O17/c1-14-18-27-45(57(72)91)74-60(94)48(35-40(5)6)77-58(92)46(28-19-15-2)75-61(95)50(38-86)80-65(99)55(42(9)16-3)81-54(90)37-73-67(101)69(12)32-24-22-20-21-23-25-33-70(13,83-62(96)49(36-41(7)8)78-64(98)52-29-26-34-85(52)44(11)88)68(102)82-56(43(10)17-4)66(100)76-47(30-31-53(71)89)59(93)79-51(39-87)63(97)84-69/h20-21,40-43,45-52,55-56,86-87H,14-19,22-39H2,1-13H3,(H2,71,89)(H2,72,91)(H,73,101)(H,74,94)(H,75,95)(H,76,100)(H,77,92)(H,78,98)(H,79,93)(H,80,99)(H,81,90)(H,82,102)(H,83,96)(H,84,97)/t42-,43-,45-,46-,47-,48-,49-,50-,51-,52-,55-,56-,69-,70+/m0/s1
Standard InChI Key: ZYDAFJIWJSHZGB-AHSPYXSFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1444.83 | Molecular Weight (Monoisotopic): 1443.9065 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Ruiz-Santaquiteria M, de Castro S, Toro MA, de Lucio H, Gutiérrez KJ, Sánchez-Murcia PA, Jiménez MÁ, Gago F, Jiménez-Ruiz A, Camarasa MJ, Velázquez S.. (2018) Trypanothione reductase inhibition and anti-leishmanial activity of all-hydrocarbon stapled α-helical peptides with improved proteolytic stability., 149 [PMID:29501944] [10.1016/j.ejmech.2018.02.071] |
2. Ruiz-Santaquiteria M, de Castro S, Toro MA, de Lucio H, Gutiérrez KJ, Sánchez-Murcia PA, Jiménez MÁ, Gago F, Jiménez-Ruiz A, Camarasa MJ, Velázquez S.. (2018) Trypanothione reductase inhibition and anti-leishmanial activity of all-hydrocarbon stapled α-helical peptides with improved proteolytic stability., 149 [PMID:29501944] [10.1016/j.ejmech.2018.02.071] |
Source(1):